Degradable temperature-sensitive mesoporous silicon nanoparticle system for light controlled release drugs
A nanoparticle and mesoporous silicon technology, which is applied in the field of medicine, can solve the problems of weakening the drug-carrying capacity of the carrier, controlling the release process, and not being able to drug, and achieve the effect of reducing the cumulative toxicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0056] refer to figure 1 The preparation method of the degradable temperature-sensitive mesoporous silicon nanoparticle system for light-controlled drug release comprises the following steps:
[0057] 1) preparing diselenide-bridged mesoporous silicon particles;
[0058] 2) Coating a temperature-sensitive layer on the surface of the diselenide-bridged mesoporous silicon particles to obtain temperature-sensitive mesoporous silicon particles;
[0059] 3) Loading chemicals on the mesoporous silicon particles inside the temperature-sensitive mesoporous silicon particles;
[0060] 4) loading a photosensitizer on the surface of the temperature-sensitive mesoporous silicon particles to obtain the degradable temperature-sensitive mesoporous silicon nanoparticle system for light-controlled drug release.
[0061] figure 1 Among them, 1 represents the diselenide-bridged mesoporous silicon particles, 2 represents the temperature-sensitive layer, 3 represents the chemical drug, and 4 re...
Embodiment 1
[0067] The preparation method of the degradable temperature-sensitive mesoporous silicon nanoparticle system for light-controlled drug release provided in this example includes the following steps:
[0068] 1. Preparation of diselenide-bridged mesoporous silicon nanoparticles: MSN
[0069] Get 0.6g cetyltrimethylammonium toluenesulfonate (CTAT) and 0.15g triethanolamine (TEAH 3 ) into 40 mL of deionized water, stirred at 80°C for 30 min, and then added bis[3-(triethoxysilyl)propyl] diselenide (BTESePD) and ethyl orthosilicate dropwise according to the mass ratio of 1 to 8. Mixture of esters (TEOS) (mixture of TEOS and BTESePD: CTAT and TEAH 3 reaction product=1~8), continue to stir for 4 hours, after three times of centrifugation washing with ethanol, adopt 1% ammonium nitrate to reflux the product after centrifugation washing for 12h; wash with ethanol again, obtain the mesoporous of diselenide bridge Silicon particles: MSN, saved for future use.
[0070] 2. Preparation ...
Embodiment 2
[0082] Embodiment 2: the performance measurement of nanoparticle
[0083] 1. Infrared characterization of MSN, MSN-MPS and MSN-NIPAM
[0084] The powders of MSN, MSN-MPS and MSN-NIPAM were taken respectively for infrared measurement, the results are shown in figure 2 . It can be seen that when MPS is coupled, the -CH of MPS can be observed at 3000-2750 nm. 2 and -CH 3 Signal, when the temperature-sensitive layer is further coated, the -C=O and N-H signals of NIPAM can be observed between 1700 and 1500 nm, indicating the successful preparation of MSN-NIPAM.
[0085] 2. Thermogravimetric analysis (TGA) of MSN, MSN-MPS and MSN-NIPAM
[0086] 10 mg of MSN, MSN-MPS and MSN-NIPAM powders were taken respectively for thermogravimetric analysis. The test conditions were to raise the temperature at a rate of 10°C / min under a nitrogen flow of 100mL / min, and measure the mass change of each substance from room temperature to 800°C. The results are as follows image 3 As shown, it can...
PUM
| Property | Measurement | Unit |
|---|---|---|
| particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



